INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
04/01/2026
Back to search
Official data from USPTO
BLUECLINICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/02/2026
Trademark type
Combined
Nice classes
42
Filing date
10/16/2017
Registration date
01/15/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/01/2025
Last transaction
04/02/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
PT
Examiner
LEE, DOUGLAS
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "BLUECLINICAL" with the word "BLUE" in blue and the word "CLINICAL" in dark blue and a light blue and white wavy line within three squares in a row in light blue, blue and dark blue.
Holders and representatives
Holders
Blueclinical - Investigação e Desenvolvimento em Saúde, Lda.
Representatives
David A. Weinstein
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and industrial research servicesresearch and development in the pharmaceuticalbiotechnology and medical device sectors; scientific research for medicinal purposes; scientific and technological servicespharmaceutical and biopharmaceutical drug development and testing servicescomputer software design and database development and maintenance in the fields of pharmaceuticalsbiotechnologymedical devices; scientific consultancy services for others in the fields of pharmaceuticalsbiotechnologymedical devices; medical research; biological research; clinical researchdesigningconductingmanagingmonitoringanalyzing and reporting non-clinical studies and clinical trialsin the fields of pharmaceuticalsbiotechnology and medical devices; biochemistry research services; drug discovery; research and development in the pharmaceutical and biotechnology sectors; drug discovery services; scientific research and analysislaboratory testing services in the fields of pharmaceuticalsbiomarkerspharmacogenomicsproteomicsbiotechnologymedical devices; biological analysis services
Publications
History of USPTO decisions and trademark events.
35 publications found
C71T
CANCELLED SECTION 71
08/01/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/15/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/21/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/02/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
05/02/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/15/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
01/15/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/30/2018
PUBO
PUBLISHED FOR OPPOSITION
10/30/2018
GPNX
NOTIFICATION PROCESSED BY IB
10/26/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/10/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/10/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/10/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/24/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
09/17/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/17/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
09/17/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/17/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/12/2018
GNFR
FINAL REFUSAL E-MAILED
09/12/2018
CNFR
FINAL REFUSAL WRITTEN
09/12/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/30/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/30/2018
ALIE
ASSIGNED TO LIE
08/30/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/14/2018
RFNT
REFUSAL PROCESSED BY IB
04/13/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/28/2018
RFRR
REFUSAL PROCESSED BY MPU
03/28/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/23/2018
CNRT
NON-FINAL ACTION WRITTEN
03/22/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/20/2018
DOCK
ASSIGNED TO EXAMINER
03/16/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/16/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/15/2018
Continuous trademark protection
Get notified about every new filing that threatens BLUECLINICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.